Biopharmaceutical company Hasten makes strategic leap forward
Hasten Biopharmaceutical Co Ltd announced the completion of the market authorization transfers for 11 pharmaceutical products across several key Asia-Pacific markets on June 16, marking a strategic leap forward in the domestic biopharmaceutical company’s regional expansion. The markets include China’s Hong Kong Special Administrative Region, Malaysia, the Philippines, and Singapore, and the transferred products are…